 |
|
|
|
|
Welcome
to the
Vétoquinol UK site |
|
We
at Vétoquinol cordially invite
you to look around
our website, with
a click of your mouse you can now link your day-to-day
practice with the latest developments from Vétoquinol.
For nearly 80 years the Vétoquinol group has
been dedicated to animal health and the veterinary
surgeons that work in it. As a result of its own
research and in collaboration with partners, Vétoquinol
regularly provides new and innovative products to
the profession. Now the 10th largest veterinary company
in the world, we continue to seek solutions to the
problems in veterinary practice.
|
|
|
|
|
Forcyl: Think Short-Acting for Long-Term Benefits
01/11/2011 |
|
November 2011 sees the launch of Forcyl, an innovative injectable anti-infective for the targeted therapeutic treatment of respiratory infections in cattle, from Vétoquinol UK Ltd.
Forcyl is a patented 16% marbofloxacin solution, registered as a single intramuscular injection, ensuring a high level of compliance.
Forcyl follows the SISAAB concept (single injection short acting antibiotic), with an optimised dosage to minimise the risk of development of antibiotic resistance. Shorter exposure time limits the opportunity for resistance to develop. The innovative formulation means a lower volume of administration (10 ml for 160 kg body weight) is required. Other benefits of Forcyl include excellent injection site tolerance and short withdrawal periods (meat: 5 days, milk: 48 hours). Think Short-Acting for Long-Term Benefits. |
|
Vetoquinol Launches Cimalgex
27/10/2011 |
|
Vetoquinol have launched Cimalgex, a new non-steroidal anti-inflammatory drug (NSAID) which contains Cimicoxib. Cimalgex is licensed for the treatment of pain and inflammation associated with osteoarthritis, and the management of peri-operative pain due to orthopaedic or soft tissue surgery, in dogs.
For further information on canine pain and Cimalgex please visit www.cimydog.co.uk |
|
Flexadin UCII – Finally a product that will redefine the standards of equine joint supplements
25/10/2011 |
|
Vetoquinol are delighted to announce a first in Europe in terms of a new and innovative approach to joint health management through nutrition. Equistro’s Flexadin UCII is the latest addition to the Flexadin Range. It contains the revolutionary new ingredient UC-II® one of the most effective and influential ingredients available that aids and supports healthy joint function. UC-II® is a native biologically active type II collagen that has been extracted in a patented process that preserves its bioactivity making it highly available and beneficial to equine joints.
To celebrate the launch of Flexadin UCII we are offering a £10 money off voucher available through purchases of Horse & Hound magazine starting from November 10th.
Caitríona Mullin, Equine Product Manager at Vetoquinol UK Ltd comments, “We are very excited about the launch of Flexadin UCII in the UK and Ireland, we have already received excellent feedback from our German and French colleagues. Flexadin UCII is a product that will further enhance our premium range of equine supplements formulated specifically for the performance horse. |
|
|
|
|
|
|
|
|
